Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartphone reminders could help forgetful patients stick to their pills

NCT ID NCT07718334

Disease control Sponsor: Mansoura University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests whether a mobile app that sends medication reminders can help people with chronic diseases and mild memory problems take their medicines more consistently. Participants use the app on their smartphones to receive alerts and track their doses. The goal is to see if this simple digital tool improves adherence and supports better self-management.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a mobile application that sends medication reminders and tracks adherence
What this could lead to
If effective, this app could offer a simple, low-cost way to help people with memory problems stick to their medication schedules, potentially improving health outcomes.
What could go wrong
This is a small, early-stage study without a control group, so results may not be conclusive. Success depends on patients consistently using the app, which may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 193 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients diagnosed with one or more chronic diseases requiring regular long-term medication. * Patients exhibiting mild-to-moderate memory impairment or cognitive decline as screened by the Mini-Mental State Examination (MMSE). * Patients who personally own and are capable of operating a smartphone or have a primary caregiver willing to manage the mobile application. * Patients aged 18 years and older. * Patients who provide voluntary informed consent to participate in the study. Exclusion Criteria: * Patients with severe cognitive impairment or advanced dementia who cannot interact with mobile technology even with caregiver assistance. * Patients with severe acute clinical complications or unstable psychiatric conditions. * Patients participating in another concurrent clinical trial or study targeting medication adherence

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Disease Medication Adherence Memory Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic disease Memory impairment

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Outpatient Clinics, Delta University for Science and Technology

    RECRUITING

    Gamasa, Dakahlia Governorate, Egypt

  • Outpatient Clinics, Kafr El-Sheikh Hospital

    RECRUITING

    Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.